Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the symbol lookup tool.
Alphabetize the sort order of my symbols
ETFs with RGEN as a Top 10 Holding*
|Weighting||ETF Name (Symbol)||100-Day Price Change (%)|
|2.03%||Guggenheim S&P Smallcap 600 Pure Growth ETF (RZG)||-3.43 (-4.22%)|
|1.41%||SPDR Series Trust SPDR S&P Biotech ETF (XBI)||-22.70 (-13.61%)|
|0.56%||Wilshire Micro-Cap ETF (based on the Wilshire US Micro-Cap Ind (WMCR)||-2.97 (-10.06%)|
**Green highlights the top performing ETF by % change in the past 100 days.
Company Description (as filed with the SEC)
The following discussion of our business contains forward-looking statements that involve risks and uncertainties. When used in this report, the words “intend,” “anticipate,” “believe,” “estimate,” “plan” and “expect” and similar expressions as they relate to us are included to identify forward-looking statements. Our actual results could differ materially from those anticipated in these forward-looking statements and are a result of certain factors, including those set forth under “Risk Factors” and elsewhere in this Annual Report on Form 10-K. Overview Repligen Corporation (“Repligen,” the “Company” or “we”) is a life sciences company that develops, manufactures and markets high-value, consumable bioprocessing products for life sciences and biopharmaceutical companies worldwide. We are a world-leading manufacturer of both native and recombinant forms of Protein A, critical reagents used in biomanufacturing to purify monoclonal antibodies, a type of biologic drug. ... More ...